EDITORIAL

Unlike many editorials, this one is not a criticism of thereferenced study. Rather, the opposite, as the study by Buchkowsky and Jewesson1 in this issue of The Annals is a nicely done piece of work on a topic that has grown in im-portance and controversy throughout the health profes-sions in the past couple of decades. It is important to con-sider the reactions that readers will have to the study. They will range from disinterest, to average interest from people who recognize what was truly stated and no more, to oth-ers who will zealously contend that the findings are further proof that any research/publication that has any attachment to industry is worthless, biased drivel. It is this latter reac-tion that needs consideration, because we are all biased when it comes to science, be it researchers in the laborato-ry, the Phase I unit, or 19th site of a multicenter trial, or av-erage clinicians who are choosing therapies for their pa